Trial Profile
Impact of basiliximab induction therapy in renal transplant patients receiving a triple immunosuppression regimen
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2015
Price :
$35
*
At a glance
- Drugs Basiliximab (Primary) ; Corticosteroids; Mycophenolate mofetil; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 06 Nov 2015 New trial record
- 01 Oct 2015 Results published in the Transplantation Proceedings
- 01 Oct 2015 Patients underwent renal transplantation between Jan 2010 and Dec 2011, according to results published in Transplantation Proceedings.